alexa
Reach Us +44-1235425476
Maurizio Chiriva-Internati D | OMICS International
ISSN: 2155-9619

Journal of Nuclear Medicine & Radiation Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

Clinical Oncology & Radiation Therapy

Singapore, Singapore
Share This Page

Maurizio Chiriva-Internati D

Assistant Professor, Departments of Hematology and Oncology, Texas Tech University Health Sciences Center School of Medicine, Lubbock, Texas, USA

Biography

Maurizio Chiriva-Internati D is currently working as an Assistant Professor, Departments of Hematology and Oncology, Texas Tech University Health Sciences Center School of Medicine, Lubbock, Texas, USA. For the past decade, he has been investigating tumor antigens as therapeutic and diagnostic tools. His research has led to the identification of novel cancer testis antigens for the development of immunotherapeutic strategies against solid and non-solid tumors. Furthermore, his research is focused on developing new therapies for multiple myeloma, ovarian and lung cancer, and prostate cancer and melanoma. His basic science research is on immunotherapy of human cancer by the identification of new tumor (-associated) genes, antigens cancer testis antigens, epitopes and biomarkers and by understanding the basic biology of dendritic cells and the basic immunology of cancer.

 
Research Interest
Acute toxicity; High-dose-rate; HDR brachytherapy; Prostate cancer; Quality of life 
Publications

Global Speakers in the subject

Global Experts in the subject

Top